DURAZZO, Marilena
DURAZZO, Marilena
SCIENZE MEDICHE
"Prevalence of diabetes mellitus immunologic marker in patients with chronic hepatitis C before and after interferon therapy"
1997-01-01 Durazzo M;Mariani M.G;Biava MA;Clerico A;D'Errico N;Sacchi C;Tabone M;Saracco G;Rizzetto M;Pagano G.
A high dietary saturated fat is associated with insulin resistance in non-alcoholic steatohepatitis.
2003-01-01 G. Musso; M. Durazzo; F. De Michieli; R. Gambino; M. Cassader; E. Fagà; E. Morello; G. Biroli; G. Pagano
Alterations of spermatogenetic parameters in HCV infection before and during antiviral treatment.
2004-01-01 Di Bisceglie C.; Durazzo M.; Lanfranco F.; Bertagna A.; Morello E.; Premoli A.; Tagliabue M.; Taliano M.; Brocato L.; Manieri C.
Anti GOR in hepatitis D: specific association with hepatitis C virus superinfection
1992-01-01 Durazzo M; Michel G; Philipp T; Braun H-B; Lutting B; Rizzetto M; Manns M.
Antibodies against GOR in patients undergoing orthotopic liver trasplantation (OLT)
1994-01-01 Durazzo M;Scaglione L;Abate M;Biava M-A;Touscoz G-A;Smedile A;Rizzetto M
Association of microsomal triglyceride transfer protein 493-T variant with resistin levels and c-reactive protein.
2006-01-01 Gambino R; Bo S; Uberti B; Alemanno N; Ghione F; Guidi S; Durazzo M; Pagano G; Cassader M
Autoantibodies to glutamic acid decarboxilase (anti-GAD) in patients with chronic hepatitis C.
1996-01-01 R.Gambino; G.Saracco; G.M.Mariani; A.Maccagnani; M.A.Biava; R.Arcari; M.Cassader; M.Durazzo
Autoanticorpi antidecarbossilasi dell'acido glutammico (anti-Gad) in pazienti con epatite cronica C.
1996-01-01 M.Durazzo; R.Gambino; M.A.Biava; G.M.Mariani; A.Clerico; F.Baracchi; A.Maccagnani; G.Pagano.
Autoimmunty in patients with chronic hepatitis type D and C
1994-01-01 Durazzo M,Schmidt E,Loges S,Michel G,Rosina F;Saracco G,Brunetto M-R,Smedile A,Scaglione L,Biava M-A,Borghesio E,Manns M-P,Rizzetto M
Definition of a novel CYP2D6 epitope in autoimmune hepatitis type 2 and in chronic hepatitis C
1998-01-01 Obermayer-Straub P.;Sugimura T;Braun S;Luttig B;Loges S;Kayser A; Durazzo M; Strassburg C;Manns M.P
Dietary habits and their relations to insulin sensitivity in non-alcoholic steatohepatitis.
2003-01-01 G. Musso; M. Durazzo; F. De Michieli; R. Gambino; M. Cassader; E. Faga’; E. Morello; G. Biroli; G. Pagano.
Does HCV infection treatment impair spermatogenesis?
2005-01-01 Di Bisceglie C.; Durazzo M.; Bertagna A.; Brocato L.; Premoli A.; Morello E.; Carello M.; Barberis A.M.; Tagliabue M.; Lanfranco F.; Manieri C.
HCV infection and thyroid dysfunction
1995-01-01 Durazzo M;Gallone G;Sacchi C;Scaglione L;Fonzo D;Pagano G;Rizzetto M.
Hepatitis C virus :clinical significance of anti-HCV and HCV-RNA and characterization of an Italian isolate
1989-01-01 Baldi M;Negro F;Saracco G;Manzini P;Lavarini C;Touscoz G; Durazzo M;Triolo G;Amoroso A;Oliveri F;Rizzetto M;Marzano A;Weiner A;Houghton M;Bonino F.
Hepatitis Delta Virus (HDV) RNA species in liver and serum of patients with chronic type D hepatitis
1989-01-01 Smedile A;Chiaberge E;Rosina F;Brunetto M-R;Ponzetto A;Saracco G;Durazzo M;Bonino F;Rizzetto M
Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C virus (HCV) infection
1992-01-01 Durazzo M;Philipp T;Luttig B;Loges S;Schmidt E;Rizzetto M;Manns M-P.
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)?
2007-01-01 A. Variola; M. Durazzo; G. Niro; A. Premoli; V. Baldo; R. Gambino; G. Musso; M. Cassader; S. Bo; F. Ferrara; A. Bressan; E.R. Rizzotto; A. Floreani.
La condizione di normopeso, sovrappeso e obeso.
2012-01-01 P. Villois; G. Musso; R. Gambino; M. Durazzo; M. Cassader; P. Cavallo-Perin; S. Bo.
Low levels of adiponectin correlate with the severity of nonalcoholic steatohepatitis after an oral fat load.
2005-01-01 R.Gambino; G.Musso; M.Durazzo; G.Biroli; M.Carello; E.Fagà; G.Pacini; F.De Michieli; L.Rabbione; A.Premoli; G.Pagano; M.Cassader.
Modification of hormonal and seminal parameters during HCV infection treatment.
2006-01-01 Bertagna A.; Di Bisceglie C.; Durazzo M.; Premoli A.; Fagà E.; Barberis A.M.; Taliano M.; Gariano A.; Manieri C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
"Prevalence of diabetes mellitus immunologic marker in patients with chronic hepatitis C before and after interferon therapy" | 1997 | Durazzo M;Mariani M.G;Biava MA;Clerico A;D'Errico N;Sacchi C;Tabone M;Saracco G;Rizzetto M;Pagano G. | |
A high dietary saturated fat is associated with insulin resistance in non-alcoholic steatohepatitis. | 2003 | G. Musso; M. Durazzo; F. De Michieli; R. Gambino; M. Cassader; E. Fagà; E. Morello; G. Biroli; G. Pagano | |
Alterations of spermatogenetic parameters in HCV infection before and during antiviral treatment. | 2004 | Di Bisceglie C.; Durazzo M.; Lanfranco F.; Bertagna A.; Morello E.; Premoli A.; Tagliabue M.; Taliano M.; Brocato L.; Manieri C. | |
Anti GOR in hepatitis D: specific association with hepatitis C virus superinfection | 1992 | Durazzo M; Michel G; Philipp T; Braun H-B; Lutting B; Rizzetto M; Manns M. | |
Antibodies against GOR in patients undergoing orthotopic liver trasplantation (OLT) | 1994 | Durazzo M;Scaglione L;Abate M;Biava M-A;Touscoz G-A;Smedile A;Rizzetto M | |
Association of microsomal triglyceride transfer protein 493-T variant with resistin levels and c-reactive protein. | 2006 | Gambino R; Bo S; Uberti B; Alemanno N; Ghione F; Guidi S; Durazzo M; Pagano G; Cassader M | |
Autoantibodies to glutamic acid decarboxilase (anti-GAD) in patients with chronic hepatitis C. | 1996 | R.Gambino; G.Saracco; G.M.Mariani; A.Maccagnani; M.A.Biava; R.Arcari; M.Cassader; M.Durazzo | |
Autoanticorpi antidecarbossilasi dell'acido glutammico (anti-Gad) in pazienti con epatite cronica C. | 1996 | M.Durazzo; R.Gambino; M.A.Biava; G.M.Mariani; A.Clerico; F.Baracchi; A.Maccagnani; G.Pagano. | |
Autoimmunty in patients with chronic hepatitis type D and C | 1994 | Durazzo M,Schmidt E,Loges S,Michel G,Rosina F;Saracco G,Brunetto M-R,Smedile A,Scaglione L,Biava M-A,Borghesio E,Manns M-P,Rizzetto M | |
Definition of a novel CYP2D6 epitope in autoimmune hepatitis type 2 and in chronic hepatitis C | 1998 | Obermayer-Straub P.;Sugimura T;Braun S;Luttig B;Loges S;Kayser A; Durazzo M; Strassburg C;Manns M.P | |
Dietary habits and their relations to insulin sensitivity in non-alcoholic steatohepatitis. | 2003 | G. Musso; M. Durazzo; F. De Michieli; R. Gambino; M. Cassader; E. Faga’; E. Morello; G. Biroli; G. Pagano. | |
Does HCV infection treatment impair spermatogenesis? | 2005 | Di Bisceglie C.; Durazzo M.; Bertagna A.; Brocato L.; Premoli A.; Morello E.; Carello M.; Barberis A.M.; Tagliabue M.; Lanfranco F.; Manieri C. | |
HCV infection and thyroid dysfunction | 1995 | Durazzo M;Gallone G;Sacchi C;Scaglione L;Fonzo D;Pagano G;Rizzetto M. | |
Hepatitis C virus :clinical significance of anti-HCV and HCV-RNA and characterization of an Italian isolate | 1989 | Baldi M;Negro F;Saracco G;Manzini P;Lavarini C;Touscoz G; Durazzo M;Triolo G;Amoroso A;Oliveri F;Rizzetto M;Marzano A;Weiner A;Houghton M;Bonino F. | |
Hepatitis Delta Virus (HDV) RNA species in liver and serum of patients with chronic type D hepatitis | 1989 | Smedile A;Chiaberge E;Rosina F;Brunetto M-R;Ponzetto A;Saracco G;Durazzo M;Bonino F;Rizzetto M | |
Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C virus (HCV) infection | 1992 | Durazzo M;Philipp T;Luttig B;Loges S;Schmidt E;Rizzetto M;Manns M-P. | |
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)? | 2007 | A. Variola; M. Durazzo; G. Niro; A. Premoli; V. Baldo; R. Gambino; G. Musso; M. Cassader; S. Bo; F. Ferrara; A. Bressan; E.R. Rizzotto; A. Floreani. | |
La condizione di normopeso, sovrappeso e obeso. | 2012 | P. Villois; G. Musso; R. Gambino; M. Durazzo; M. Cassader; P. Cavallo-Perin; S. Bo. | |
Low levels of adiponectin correlate with the severity of nonalcoholic steatohepatitis after an oral fat load. | 2005 | R.Gambino; G.Musso; M.Durazzo; G.Biroli; M.Carello; E.Fagà; G.Pacini; F.De Michieli; L.Rabbione; A.Premoli; G.Pagano; M.Cassader. | |
Modification of hormonal and seminal parameters during HCV infection treatment. | 2006 | Bertagna A.; Di Bisceglie C.; Durazzo M.; Premoli A.; Fagà E.; Barberis A.M.; Taliano M.; Gariano A.; Manieri C. |